ITeos Therapeutics Inc
NASDAQ:ITOS
| Market Cap (Intraday) | 964.43M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $27.32 |
| 50-Day MA | $27.23 |
| 200-Day MA | $28.40 |
ITeos Therapeutics Inc Stock, NASDAQ:ITOS
139 Main Street, Cambridge, Massachusetts 02142
United States of America
Phone: +1.339.217.0161
Number of Employees: 62
Description
iTeos Therapeutics, Inc. engages in the development of biopharmaceuticals therapeutic products and services. It offers immuno-oncology therapeutics for patients. The company was founded by Michel Detheux in April 2012 and is headquartered in Cambridge, MA.